Literature DB >> 31097227

Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model.

Masashi Kakae1, Shota Tobori1, Misa Morishima1, Kazuki Nagayasu1, Hisashi Shirakawa2, Shuji Kaneko1.   

Abstract

Microglia are immune cells in the central nervous system (CNS) and essential for homeostasis that are important for both neuroprotection and neurotoxicity, and are activated in a variety of CNS diseases. Microglia aggravate cognitive impairment induced by chronic cerebral hypoperfusion, but their precise roles under these conditions remain unknown. Here, we used PLX3397, a colony-stimulating factor 1 receptor inhibitor, to deplete microglia in mice with chronic cerebral hypoperfusion induced by bilateral common carotid artery stenosis (BCAS). Cognitive impairment induced 28 days after BCAS was significantly improved in mice fed a diet containing PLX3397. In PLX3397-fed mice, microglia were depleted and white matter injury induced by BCAS was suppressed. In addition, the expression of proinflammatory cytokines, interleukin 6 and tumor necrosis factor alpha, was suppressed in PLX3397-fed mice. Taken together, these findings suggest that microglia play destructive roles in the development of cognitive impairment and white matter injury induced by chronic cerebral hypoperfusion. Thus, microglia represent a potential therapeutic target for chronic cerebral hypoperfusion-related diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic cerebral hypoperfusion; Cognitive impairment; Colony-stimulating factor 1; Cytokines; Microglia; White matter injury

Year:  2019        PMID: 31097227     DOI: 10.1016/j.bbrc.2019.05.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Regulatory microRNAs and vascular cognitive impairment and dementia.

Authors:  Jing Zhang; Ping Sun; Chao Zhou; Xuejing Zhang; Feifei Ma; Yang Xu; Milton H Hamblin; Ke-Jie Yin
Journal:  CNS Neurosci Ther       Date:  2020-12       Impact factor: 5.243

Review 2.  Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy.

Authors:  Jinming Han; Heela Sarlus; Zbigniew K Wszolek; Virginija Danylaité Karrenbauer; Robert A Harris
Journal:  Acta Neuropathol Commun       Date:  2020-12-07       Impact factor: 7.801

3.  Microglia/macrophage diversities in central nervous system physiology and pathology.

Authors:  Di Xie; Maxine He; Xiaoming Hu
Journal:  CNS Neurosci Ther       Date:  2019-12       Impact factor: 5.243

4.  Underestimated Peripheral Effects Following Pharmacological and Conditional Genetic Microglial Depletion.

Authors:  Jinming Han; Yueshan Fan; Kai Zhou; Keying Zhu; Klas Blomgren; Harald Lund; Xing-Mei Zhang; Robert A Harris
Journal:  Int J Mol Sci       Date:  2020-11-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.